
Readiness-to-Change Scores Predict Alcohol Treatment Uptake
Nov 28, 2025 · Emergency department patients with alcohol use disorder who report higher readiness-to-change scores are more likely to enroll in treatment within 30 days, a study finds.
Current Risk Scores Miss Nearly Half of First Heart Attacks
Nov 25, 2025 · Nearly half of adults with a first myocardial infarction show low or borderline risk on current risk estimators. Most develop symptoms only within 48 hours and would not qualify for statins …
The Art of Sharing: Telling Stories With Your Patients - Medscape
Jun 3, 2025 · Reading the stories of others who have walked the same walk can be enlightening, but it is really the process of sharing one’s own story that can be the most therapeutic.
Virtual Reality Makes Allergy Testing Less Scary for Kids
The use of virtual reality during skin prick testing cuts children’s anxiety, fear, and pain and achieves 100% procedural compliance.
Combo Falls Short for Venous Pressure Reduction in Cirrhosis
The hepatic venous pressure gradient is not reduced, and fluid retention persists across several different doses of zibotentan with dapagliflozin.
Work Performance May Be Impaired Years After COVID - Medscape
4 days ago · Individuals with post-COVID condition report lower work ability and greater impairments in work performance for 3 years after infection than those without the condition.
Lebrikizumab Safe and Effective in Atopic Dermatitis - Medscape
Oct 16, 2025 · A real-world study shows that lebrikizumab is safe and effective for patients with moderate-to-severe atopic dermatitis, including those with prior exposure to biologics or JAK inhibitors.
Can Endurance Exercise Be Harmful? - Medscape
Aug 30, 2024 · The study measured physical activity of any variety and included physically taxing sports like golf (without a cart). So it was not an assessment of the dangers of endurance exercise.
Exercise Added to Standard Care Promising for Adult ADHD
Nov 24, 2025 · Structured physical exercise plus standard care compared with standard care alone may alleviate symptoms of adult attention-deficit/hyperactivity disorder, new ...
Tezepelumab Shows Superior Efficacy in Allergic Asthma - Medscape
Nov 10, 2025 · In patients with moderate-to-severe allergic asthma, tezepelumab yields the greatest reduction in exacerbations among biologics compared with placebo.